Oncology Central

BMI variation increases recurrence risk in women with early-stage breast cancer

0

Aims: The prognostic role of BMI variation during and/or after treatments for early-stage breast cancer is still unknown. Patients & methods: The χ2 test was conducted to explore the correlation between breast cancer recurrence and BMI changes in 520 early-stage breast cancer patients. Cox proportional hazard models were used to analyze the association of BMI changes, baseline BMI, known prognostic factors and recurrences. Results: BMI gain was significant determinant of recurrences (p = 0.0008).

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.

Share:

Insights

Videos

News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.